Drug intelligence / Profile preview

TOTUM-854

Development stage
Unknown
Lead developer
Valbiotis
Administration
Oral
01

Overview

TOTUM-854 is a **polyphenol-rich blend of six plant extracts** developed as a proprietary botanical formulation for vascular protection and the prevention or management of mild to moderate hypertension. It is not a single chemical entity but a standardised combination whose individual plant-derived compounds have been shown to impact inflammation and oxidative stress. Its mechanism of action includes: - Inhibition of angiotensin-converting enzyme 1 (ACE-1) activity, which reduces the production of angiotensin II and thus lowers vasoconstriction and blood pressure. - Reduction of oxidative stress by lowering NADPH oxidase (NOX2) mediated reactive oxygen species (ROS) production. - Reduction of inflammatory markers (IL-1β, MCP-1, and VCAM-1), which are implicated in endothelial dysfunction. TOTUM-854 shows bioactive metabolite absorption in humans and has demonstrated efficacy in rodent models and ex vivo human vascular assays. Its development is ongoing through clinical trials for **moderate hypertension** and potentially as a preventive strategy against cardiovascular disease. The developer is Valbiotis, a French nutraceutical company.[1][2][3][4][5]

Brand names
TOTUM-854TOTUM854TOTUM 854TOTUM•854
Other names
TOTUM-854TOTUM854TOTUM 854T-854T854T 854
02

Targets

NOX2 (NADPH oxidase 2)VCAM1 (Vascular cell adhesion molecule 1)ACE (Angiotensin Converting Enzyme)CCL2 (C-C motif chemokine 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on TOTUM-854.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOTUM-854.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call